Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

One of the current goals in vaccine development is the noninvasive administration of protective antigens via mucosal surfaces. In this context, the gut-associated lymphoid tissues have already been extensively explored. Vaccination via the nasal route has only recently been the focus of intensive in...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Infect Immun
Hauptverfasser:	Mielcarek, N, Cornette, J, Schacht, A M, Pierce, R J, Locht, C, Capron, A, Riveau, G
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1997
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176094/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9009311/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.65.2.544-550.1997
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!